Market Place
Sourcing Support
Clarus Therapeutics Announces Completion of Auction for Sale of JATENZO
18 Oct 2022 //
GLOBENEWSWIRE
Clarus Therapeutics Holdings,. Announces Plan for Near-Term Sale of JATENZO®
05 Sep 2022 //
GLOBENEWSWIRE
Clarus` fate in limbo as lead drug Jatenzo sputters
20 Aug 2022 //
FIERCEPHARMA
Clarus Therapeutics Reports Second Quarter 2022 Financial Results
18 Aug 2022 //
GLOBENEWSWIRE
Clarus Therapeutics Announces NoA for Additional Patent Claims Covering JATENZO
28 Jul 2022 //
GLOBENEWSWIRE
Clarus Therapeutics to Present New Data for JATENZO at ENDO 2022
09 Jun 2022 //
GLOBENEWSWIRE
Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results
16 May 2022 //
GLOBENEWSWIRE
Clarus Therapeutics to Report First Quarter 2022 Financial and Operating Results
12 May 2022 //
GLOBENEWSWIRE
Clarus Tx Announces Notice of Allowance for Patent Claims Covering CLAR-121
10 May 2022 //
GLOBENEWSWIRE
Clarus Therapeutics to Present New Data for JATENZO at the 2022 AUA
09 May 2022 //
GLOBENEWSWIRE
Clarus Tx Announces Notice of Allowance for Patent Claims Covering JATENZO
28 Apr 2022 //
GLOBENEWSWIRE
Clarus Therapeutics Closes Upsized $30.0M Underwritten Public Offering
27 Apr 2022 //
GLOBENEWSWIRE
Underwritten Clarus Therapeutics Announces Pricing of Upsized $30.0 Million
25 Apr 2022 //
GLOBENEWSWIRE
Clarus to Present New Data for JATENZO at Androgen Society 4th Annual Meeting
19 Apr 2022 //
GLOBENEWSWIRE
Clarus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial
30 Mar 2022 //
GLOBENEWSWIRE
Clarus Therapeutics to Report Fourth Quarter and Full Year 2021 Financials
29 Mar 2022 //
GLOBENEWSWIRE
Clarus says Initiation of P 4 Trial of JATENZO for Hypogonadal Men with CKD
16 Mar 2022 //
GLOBENEWSWIRE
Clarus Tx to Present at the Oppenheimer 32nd Annual Healthcare Conference
10 Mar 2022 //
GLOBENEWSWIRE
Clarus Announces Strategic Partnerships for JATENZO with Vault Health & AssistRx
24 Feb 2022 //
GLOBENEWSWIRE
Clarus Therapeutics Announces Closing of Approximately $15 M Private Placement
07 Dec 2021 //
GLOBENEWSWIRE
Clarus Therapeutics Announces $15 Million Private Placement
03 Dec 2021 //
GLOBENEWSWIRE
Clarus Therapeutics to Report Q3 2021 Financial and Operating Results
17 Nov 2021 //
GLOBENEWSWIRE
Clarus Therapeutics Announces Two Notices of Allowance for Patent Claims
26 Oct 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.